Theravance Biopharma Inc
Biotechnology
Healthcare
TBPH
49.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
8.20
52 week high
10.47
high
8.82
52 week low
7.66
previous Close
8.32
P/E ratio
market cap
472 M
div yield
0
net incoming
-12.70 M
23.18 %
net profit margin
-75.28 %
40.00 %
operating incoming
-10.84 M
15.03 %
net change in cash
-22.97 M
-206.64 %
cash on hand
23.38 M
-49.56 %
top